Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Care Facilities

Global Health Limited engages in the provision of healthcare services in India. The company primarily offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, musculoskeletal disorders and orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, plastic, aesthetic and reconstructive surgery, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology and imaging, ophthalmology, critical care, dermatology, dentistry, ayurveda, and dietetics and nutrition. It also offers lab tests and diagnostics, homecare and elder care services, telemedicine and air ambulance services, blood bank and e-ICU services, and health plans, as well as operates pharmacies. The company operates a network of hospitals under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in New Delhi, India.

Revenue projections:

Revenue projections for MEDANTA
Revenue projections for MEDANTA

Global Health Limited's projected revenue decline from last year is likely to make investors cautious. Lower revenues often hurt a company's bottom line, leading investors to be concerned about the company's ability to maintain profitability and deliver strong financial results in the future.

Financial Ratios:

currentRatio 2.67100
forwardPE 40.66477
debtToEquity 29.86900
earningsGrowth 0.42000
revenueGrowth 0.24500
grossMargins 0.52545
operatingMargins 0.15292
trailingEps 20.70000
forwardEps 32.27364

With a current ratio of 2.671, Global Health Limited has the liquidity needed to easily service its short-term debt. The company's cash reserves and current assets are sufficient, indicating that Global Health Limited is in a strong position to meet its immediate financial obligations without difficulty.
Global Health Limited's low Debt-to-Equity ratio reflects that the company isn't heavily reliant on debt, reducing financial risk. This conservative approach suggests Global Health Limited maintains a stable financial foundation, with greater flexibility to manage future growth or challenges without over-leverage concerns.
MEDANTA's positive earnings and revenue growth point to business expansion on the horizon. The company is positioned for continued success, with increasing profits and revenue growth highlighting a strong path forward for future growth.
MEDANTA's forward EPS exceeding its trailing EPS means that the company is expected to increase profitability in the current financial year. This reflects improved earnings potential, signaling that MEDANTA is likely to outperform its previous year's financial performance.

Price projections:

Price projections for MEDANTA
Price projections for MEDANTA

The steady upward revision of MEDANTA's price projections indicates growing confidence in the company's performance. Analysts are becoming increasingly optimistic about MEDANTA's future prospects and potential for growth.

Recommendation changes over time:

Recommendations trend for MEDANTA
Recommendations trend for MEDANTA


With analysts showing a buy bias for MEDANTA, investors may be more inclined to see the stock as an attractive investment. The favorable outlook could spur increased interest, positioning MEDANTA as a safe and profitable place for investors to allocate their funds and seek growth.